Promethazine and Gleevec drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Promethazine (promethazine hydrochloride) and Gleevec (imatinib mesylate). Common drug interactions include oedema among females and bronchitis among males.

The phase IV clinical study analyzes what interactions people have when they take Promethazine and Gleevec. It is created by eHealthMe based on reports of 31 people who take the same drugs from the FDA, and is updated regularly.

What is Promethazine?

Promethazine has active ingredients of promethazine hydrochloride. It is often used in nausea. eHealthMe is studying from 32,300 Promethazine users. Check the latest studies of Promethazine.

What is Gleevec?

Gleevec has active ingredients of imatinib mesylate. It is often used in chronic myelogenous leukemia (cml). eHealthMe is studying from 35,415 Gleevec users. Check the latest studies of Gleevec.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 31, 2026

31 people who take Promethazine and Gleevec together, and have interactions are studied.

Promethazine and Gleevec drug interactions.

What are the common drug interactions of Promethazine and Gleevec, by gender? *:

female:

  1. Oedema (fluid collection in tissue)
  2. Pulmonary arterial hypertension (high blood pressure in the arteries of lungs)
  3. Pulmonary oedema (fluid accumulation in the lungs)
  4. Renal failure (kidney dysfunction)
  5. Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints)
  6. Sepsis (a severe blood infection that can lead to organ failure and death)
  7. Sinusitis (inflammation of sinus)
  8. Subdural haematoma (blood collects between the skull and the surface of the brain)
  9. Suicidal ideation
  10. Vitamin b12 decreased

male:

  1. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  2. Dyspnoea (difficult or laboured respiration)
  3. Death
  4. Drug ineffective
  5. Dry mouth
  6. Emotional disorder
  7. Eye pain
  8. Fall
  9. Foot fracture
  10. Gait disturbance

What are the common drug interactions of Promethazine and Gleevec, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Cytomegalovirus gastritis (virus infection of stomach)
  2. Malaise (a feeling of general discomfort or uneasiness)
  3. Neoplasm malignant (cancer tumour)

40-49:

  1. Cardiac failure congestive
  2. Death
  3. Dry mouth
  4. Fall
  5. Gastric cancer (stomach cancer)
  6. Pulmonary arterial hypertension (high blood pressure in the arteries of lungs)
  7. Renal failure (kidney dysfunction)
  8. Sepsis (a severe blood infection that can lead to organ failure and death)

50-59:

  1. Influenza
  2. Myocardial infarction (destruction of heart tissue resulting from obstruction of the blood supply to the heart muscle)
  3. Neuropathy peripheral (surface nerve damage)
  4. Pneumonia
  5. Abdominal pain upper
  6. Arthralgia (joint pain)
  7. Constipation
  8. Crying
  9. Gait disturbance
  10. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)

60+:

  1. Gastrointestinal stromal tumour (a cancer that arises from transformed cells of mesenchymal origin in gastrointestinal tract)
  2. Anaemia (lack of blood)
  3. Eye swelling
  4. Fatigue (feeling of tiredness)
  5. Haematocrit decreased
  6. Haemoglobin decreased
  7. Intra-abdominal pressure increased
  8. Joint swelling
  9. Lymphocyte count decreased
  10. Pain

What are the existing conditions these people have? *

  1. Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 8 people, 25.81%
  2. Gastrointestinal Stromal Tumor: 6 people, 19.35%
  3. Pain: 3 people, 9.68%
  4. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 3 people, 9.68%
  5. Stress And Anxiety: 2 people, 6.45%
  6. Osteoporosis (bones weak and more likely to break): 2 people, 6.45%
  7. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 6.45%
  8. Headache (pain in head): 2 people, 6.45%
  9. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 2 people, 6.45%

* Approximation only. Some reports may have incomplete information.

Do you take Promethazine and Gleevec?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Promethazine and Gleevec:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Promethazine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Gleevec:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Promethazine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Gleevec and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on promethazine hydrochloride and imatinib mesylate (the active ingredients of Promethazine and Gleevec, respectively), and Promethazine and Gleevec (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: